The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis
Open accessAbstract
The nuclear factor-κB (NF-κB) is a transcription factor that regulates the expression of genes that control cell proliferation and apoptosis, as well as genes that respond to inflammation and immune responses. There are two means of NF-κB activation: the classical pathway, which involves the degradation of the inhibitor of κBα (IκBα), and the alternative pathway, which involves the NF-κB-inducing kinase (NIK, also known as MAP3K14). The mouse growth plate consists of the resting zone, proliferative zone, prehypertrophic zone, and hypertrophic zone. The p65 (RelA), which plays a central role in the classical pathway, is expressed throughout the cartilage layer, from the resting zone to the hypertrophic zone. Inhibiting the classical NF-κB signaling pathway blocks growth hormone (GH) or insulin-like growth factor (IGF-1) signaling, suppresses cell proliferation, and suppresses bone morphogenetic protein 2 (BMP2) expression, thereby promoting apoptosis. Since the production of autoantibodies and inflammatory cytokines, such as tumor necrosis factor-α (TNFα), interleukin (IL)-1β, IL-6, and IL-17, are regulated by the classical pathways and are increased in rheumatoid arthritis (RA), NF-κB inhibitors are used to suppress inflammation and joint destruction in RA models. In osteoarthritis (OA) models, the strength of NF-κB-activation is found to regulate the facilitation or suppression of OA. On the other hand, RelB is involved in the alternative pathway, and is expressed in the periarticular zone during the embryonic period of development. The alternative pathway is involved in the generation of chondrocytes in the proliferative zone during physiological conditions, and in the development of RA and OA during pathological conditions. Thus, NF-κB is an important molecule that controls normal development and the pathological destruction of cartilage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, S., Flint, J. K., Rezvani, G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702991200 · Cited by 52
RetractedNF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S.-C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.52 · Cited by 1,891
Akiyama, H., Chaboissier, M.-C., Martin, J. F., Schedl, A., & de Crombrugghe, B. (2002) · Genes & Development · doi:10.1101/gad.1017802 · Cited by 1,721
Regulation of NF-κB by TNF family cytokines
Hayden, M. S., & Ghosh, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.05.004 · Cited by 1,115
Requirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Cheema, G. S., Roschke, V., Hilbert, D. M., & Stohl, W. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1313::aid-art223>3.0.co;2-s · Cited by 802
Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus
Zhang, J., Roschke, V., Baker, K. P., Wang, Z., Alarcón, G. S., Fessler, B. J., Bastian, H., Kimberly, R. P., & Zhou, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.6 · Cited by 734
Development of the Endochondral Skeleton
Long, F., & Ornitz, D. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008334 · Cited by 663
Limb and Skin Abnormalities in Mice Lacking IKKα
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., & Akira, S. (1999) · Science · doi:10.1126/science.284.5412.313 · Cited by 609
Takeda, S., Bonnamy, J.-P., Owen, M. J., Ducy, P., & Karsenty, G. (2001) · Genes & Development · doi:10.1101/gad.845101 · Cited by 518
Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Self-citationIKK1-deficient mice exhibit abnormal development of skin and skeleton
Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K.-F., Izpisua-Belmonte, J. C., & Verma, I. M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1322 · Cited by 469
Miagkov, A. V., Kovalenko, D. V., Brown, C. E., Didsbury, J. R., Cogswell, J. P., Stimpson, S. A., Baldwin, A. S., & Makarov, S. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13859 · Cited by 467
Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation
Simmonds, R. E., & Foxwell, B. M. (2008) · Rheumatology · doi:10.1093/rheumatology/kem298 · Cited by 381
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
Novack, D. V. (2011) · Cell Research · doi:10.1038/cr.2010.159 · Cited by 315
Nuclear factor–k B in rheumatoid synovium. Localization of P50 and P65
Handel, M. L., Mcmorrow, L. B., & Gravallese, E. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381209 · Cited by 289
Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
Palombella, V. J., Conner, E. M., Fuseler, J. W., Destree, A., Davis, J. M., Laroux, F. S., Wolf, R. E., Huang, J., Brand, S., Elliott, P. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15671 · Cited by 287
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation
Tak, P. P., Gerlag, D. M., Aupperle, K. R., Geest, D. A. V. D., Overbeek, M. J., Bennett, B. L., Boyle, D. L., Manning, A. M., & Firestein, G. S. (2001) · Arthritis & Rheumatism · Cited by 234
NF-κB modulators in osteolytic bone diseases
Xu, J., Wu, H. F., Ang, E. S. M., Yip, K., Woloszyn, M., Zheng, M. H., & Tan, R. X. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.007 · Cited by 229
McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X., Qiu, Y., Zusi, F. C., & Burke, J. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11131 · Cited by 217
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice
Wang, H., Marsters, S. A., Baker, T., Chan, B., Lee, W. P., Fu, L., Tumas, D., Yan, M., Dixit, V. M., Ashkenazi, A., et al. (2001) · Nature Immunology · doi:10.1038/89782 · Cited by 206
Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb
Kanegae, Y., Tavares, A. T., Belmonte, J. C. I., & Verma, I. M. (1998) · Nature · doi:10.1038/33429 · Cited by 203
Dai, S., Hirayama, T., Abbas, S., & Abu-Amer, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400258200 · Cited by 196
Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P., & Bravo, R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.999 · Cited by 176
Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB
Saito, T., & Tanaka, S. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1296-y · Cited by 176
Role of nuclear factor‐κB in the immune system and bone
Jimi, E., & Ghosh, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00329.x · Cited by 163
Self-citationRisk factors for progression of knee osteoarthritis
Doherty, M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06006-8 · Cited by 126
Feng, J. Q., Xing, L., Zhang, J.-H., Zhao, M., Horn, D., Chan, J., Boyce, B. F., Harris, S. E., Mundy, G. R., & Chen, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212296200 · Cited by 125
NF‐κB ‐inducing kinase is a key regulator of inflammation‐induced and tumour‐associated angiogenesis
Noort, A. R., van Zoest, K. P. M., Weijers, E. M., Koolwijk, P., Maracle, C. X., Novack, D. V., Siemerink, M. J., Schlingemann, R. O., Tak, P. P., & Tas, S. W. (2014) · The Journal of Pathology · doi:10.1002/path.4403 · Cited by 114
NF-κB–inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis
Aya, K., Alhawagri, M., Hagen-Stapleton, A., Kitaura, H., Kanagawa, O., & Novack, D. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23763 · Cited by 111
Kobayashi, H., Chang, S. H., Mori, D., Itoh, S., Hirata, M., Hosaka, Y., Taniguchi, Y., Okada, K., Mori, Y., Yano, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms13336 · Cited by 110
Ripmeester, E. G., Timur, U. T., Caron, M. M. J., & Welting, T. J. M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00018 · Cited by 110
Miyazawa, K., Mori, A., Yamamoto, K., & Okudaira, H. (1998) · Europe PMC (PubMed Central) · Cited by 104
Direct Inhibition of NF-κB Blocks Bone Erosion Associated with Inflammatory Arthritis
Clohisy, J. C. F., Roy, B. C., Biondo, C., Frazier, E. P., Willis, D., Teitelbaum, S. L., & Abu‐Amer, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5547 · Cited by 96
Caron, M. M. J., Emans, P. J., Surtel, D. A., Cremers, A., Voncken, J. W., Welting, T. J. M., & van Rhijn, L. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033467 · Cited by 83
Olivotto, E., Borzì, R. M., Vitellozzi, R., Pagani, S., Facchini, A., Battistelli, M., Penzo, M., Li, X., Flamigni, F., Li, J., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23211 · Cited by 77
Wu, S., Yang, W., & Luca, F. D. (2015) · Endocrinology · doi:10.1210/en.2014-1983 · Cited by 77
Asahara, H., Asanuma, M., Ogawa, N., et al. (1995) · PubMed · Cited by 74
NF-κB activation in human knee-joint synovial tissue during the early stage of joint inflammation
Gilston, V., Jones, H. W., Soo, C. C., et al. (1997) · Biochemical Society Transactions · doi:10.1042/bst025518s · Cited by 61
Transcriptional Network Controlling Endochondral Ossification
Hata, K., Takahata, Y., Murakami, T., & Nishimura, R. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.2.75 · Cited by 59
Murahashi, Y., Yano, F., Kobayashi, H., Makii, Y., Iba, K., Yamashita, T., Tanaka, S., & Saito, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-34830-9 · Cited by 52
NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis
Yang, C., McCoy, K., Davis, J. L., Schmidt‐Supprian, M., Sasaki, Y., Faccio, R., & Novack, D. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015383 · Cited by 47
Wu, S., Fadoju, D., Rezvani, G., & Luca, F. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803754200 · Cited by 44
In vitro selection of optimal RelB/p52 DNA-binding motifs
Britanova, L. V., Makeev, V. J., & Kuprash, D. V. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.200 · Cited by 33
Control of Osteoclast Activity and Bone Loss by IKK Subunits: New Targets for Therapy
Ruocco, M. G., & Karin, M. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_16 · Cited by 18
Constitutive activation of the alternative NF-κB pathway disturbs endochondral ossification
Nakatomi, C., Nakatomi, M., Matsubara, T., Komori, T., Doi-Inoue, T., Ishimaru, N., Weih, F., Iwamoto, T., Matsuda, M., Kokabu, S., et al. (2019) · Bone · doi:10.1016/j.bone.2019.01.002 · Cited by 17
Self-citation
Cited by
Agu, P. C., Afiukwa, C. A., Orji, O. U., Ezeh, E. M., Ofoke, I. H., Ogbu, C. O., Ugwuja, E. I., & Aja, P. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40160-2 · Cited by 1,211
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
NF‐κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration
Zhang, G., Liu, M., Chen, H., Wu, Z., Gao, Y., Ma, Z., He, X., & Kang, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13057 · Cited by 261
Hordenine Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammation
Zhang, X., Du, L., Zhang, J., Li, C., Zhang, J., & Lv, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.712232 · Cited by 17
“and TNF-α activate the inflammatory NF-κB signaling pathway, promote the secretion of inflammatory mediators, and expand the inflammatory response (Jimi et al., 2019).”
BackgroundNrf2 signaling pathway: focus on oxidative stress in osteoporosis
Gu, H.-Y., Liu, N., Lin, F.-X., & Yin, J. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07592-0 · Cited by 10
Metadata
- Authors
- Jimi, E., Huang, F., & Nakatomi, C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-12-12
- Volume
- 20
- Issue
- 24
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2996365566
- Cited by
- 321
- References
- 51
- FWCI
- 17.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.